# Neurotropism and Neuroinflammation in COVID-19 Patients With Delirium.

> **NCT04785157** · — · COMPLETED · sponsor: **University Hospital, Toulouse** · enrollment: 7 (actual)

## Conditions studied

- Covid19
- Delirium
- Post-traumatic Stress Disorder

## Interventions

- **BIOLOGICAL:** serology testing profiles description
- **BIOLOGICAL:** immune response characterization
- **OTHER:** in vivo brain PET-TSPO acquisitions
- **OTHER:** brain MRI assessment
- **BEHAVIORAL:** neurocognitive assessment

## Key facts

- **NCT ID:** NCT04785157
- **Lead sponsor:** University Hospital, Toulouse
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-06-01
- **Primary completion:** 2022-06-30
- **Final completion:** 2022-06-30
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2023-08-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04785157

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04785157, "Neurotropism and Neuroinflammation in COVID-19 Patients With Delirium.". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04785157. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*